The immune response in glaucoma: A perspective on the roles of oxidative stress

Experimental Eye Research

Volumn 93, Issue 2, 2011, Pages 178-186

  Tezel, Gülgün ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Aging; Glaucoma; Glia; Immune system; Oxidative stress; Retinal ganglion cell

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYTOKINE; HEAT SHOCK PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL PROLIFERATION; CYTOKINE PRODUCTION; GLAUCOMA; GLIA; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; MACROGLIA; NONHUMAN; OPTIC NERVE DISEASE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RISK FACTOR; SIGNAL TRANSDUCTION; TELOMERE;

AGING; ANIMALS; GLAUCOMA; HUMANS; IMMUNE SYSTEM; OPTIC NERVE DISEASES; OXIDATIVE STRESS;

EID: 80052807932     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2010.07.009     Document Type: Article

References (138)

1. Agapova O.A., Ricard C.S., Salvador-Silva M., Hernandez M.R. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 2001, 33:205-216.
2. Agrawal A., Tay J., Yang G.E., Agrawal S., Gupta S. Age-associated epigenetic modifications in human DNA increase its immunogenicity. Aging 2010, 2:93-100.
3. Ahmed F., Brown K.M., Stephan D.A., Morrison J.C., Johnson E.C., Tomarev S.I. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 2004, 45:1247-1258.
4. Banks W.A., Erickson M.A. The blood-brain barrier and immune function and dysfunction. Neurobiol. Dis. 2010, 37:26-32.
5. Bauer J., Bradl M., Hickley W.F., Forss-Petter S., Breitschopf H., Linington C., Wekerle H., Lassmann H. T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition. Am. J. Pathol. 1998, 153:715-724.
6. Bauer M.E., Jeckel C.M., Luz C. The role of stress factors during aging of the immune system. Ann. N. Y. Acad. Sci. 2009, 1153:139-152.
7. Bhattacharya S.K. Retinal deimination in aging and disease. IUBMB Life 2009, 61:504-509.
8. Broman A.T., Quigley H.A., West S.K., Katz J., Munoz B., Bandeen-Roche K., Tielsch J.M., Friedman D.S., Crowston J., Taylor H.R., Varma R., Leske M.C., Bengtsson B., Heijl A., He M., Foster P.J. Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data. Invest. Ophthalmol. Vis. Sci. 2008, 49:66-76.
9. Burgoyne C.F., Downs J.C. Premise and prediction-how optic nerve head biomechanics underlies the susceptibility and clinical behavior of the aged optic nerve head. J. Glaucoma 2008, 17:318-328.
10. Calderwood S.K., Mambula S.S., Gray P.J. Extracellular heat shock proteins in cell signaling and immunity. Ann. N. Y. Acad. Sci. 2007, 1113:28-39.
11. Caspi R.R. Ocular autoimmunity: the price of privilege?. Immunol. Rev. 2006, 213:23-35.
12. Dervan E.W., Chen H., Ho S.L., Brummel N., Schmid J., Toomey D., Haralambova M., Gould E., Wallace D.M., Prehn J.H., O'Brien C.J., Murphy D. Protein macroarray profiling of serum autoantibodies in pseudoexfoliation glaucoma. Invest. Ophthalmol. Vis. Sci. 2010, 51:2968-2975.
13. Downs J.C., Suh J.K., Thomas K.A., Bellezza A.J., Hart R.T., Burgoyne C.F. Viscoelastic material properties of the peripapillary sclera in normal and early-glaucoma monkey eyes. Invest. Ophthalmol. Vis. Sci. 2005, 46:540-546.
14. van Eden W., Koets A., van Kooten P., Prakken B., van der Zee R. Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity. Vaccine 2003, 21:897-901.
15. Feilchenfeld Z., Yucel Y.H., Gupta N. Oxidative injury to blood vessels and glia of the pre-laminar optic nerve head in human glaucoma. Exp. Eye Res. 2008, 87:409-414.
16. Forrester J.V. Privilege revisited: an evaluation of the eye's defence mechanisms. Eye 2009, 23:756-766.
17. Gordon M.O., Beiser J.A., Brandt J.D., Heuer D.K., Higginbotham E.J., Johnson C.A., Keltner J.L., Miller J.P., Parrish R.K., Wilson M.R., Kass M.A. The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 2002, 120:714-720. (discussion 829-730).
18. Govindarajan B., Junk A., Algeciras M., Salomon R.G., Bhattacharya S.K. Increased isolevuglandin-modified proteins in glaucomatous astrocytes. Mol. Vis. 2009, 15:1079-1091.
19. Grieshaber M.C., Flammer J. Does the blood-brain barrier play a role in glaucoma?. Surv. Ophthalmol. 2007, 52(Suppl. 2):S115-S121.
20. Grus F.H., Joachim S.C., Wuenschig D., Rieck J., Pfeiffer N. Autoimmunity and glaucoma. J. Glaucoma 2008, 17:79-84.
21. Hammam T., Montgomery D., Morris D., Imrie F. Prevalence of serum autoantibodies and paraproteins in patients with glaucoma. Eye 2008, 22:349-353.
22. Hernandez M.R. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog. Retin. Eye Res. 2000, 19:297-321.
23. Hernandez M.R., Luo X.X., Andrzejewska W., Neufeld A.H. Age-related changes in the extracellular matrix of the human optic nerve head. Am. J. Ophthalmol. 1989, 107:476-484.
24. Hernandez M.R., Agapova O.A., Yang P., Salvador-Silva M., Ricard C.S., Aoi S. Differential gene expression in astrocytes from human normal and glaucomatous optic nerve head analyzed by cDNA microarray. Glia 2002, 38:45-64.
25. Hernandez M.R., Miao H., Lukas T. Astrocytes in glaucomatous optic neuropathy. Prog. Brain Res. 2008, 173:353-373.
26. Hernandez M.R., Pena J.D. The optic nerve head in glaucomatous optic neuropathy. Arch. Ophthalmol. 1997, 115:389-395.
27. Hernandez M.R., Ye H. Glaucoma: changes in extracellular matrix in the optic nerve head. Ann. Med. 1993, 25:309-315.
28. Huang P., Qi Y., Xu Y.S., Liu J., Liao D., Zhang S.S., Zhang C. Serum cytokine alteration is associated with optic neuropathy in human primary open angle glaucoma. J. Glaucoma 2010, 19:324-330.
29. Inman D.M., Horner P.J. Reactive nonproliferative gliosis predominates in a chronic mouse model of glaucoma. Glia 2007, 55:942-953.
30. Joachim S.C., Bruns K., Lackner K.J., Pfeiffer N., Grus F.H. Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr. Eye Res. 2007, 32:501-509.
31. Joachim S.C., Reichelt J., Berneiser S., Pfeiffer N., Grus F.H. Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch. Clin. Exp. Ophthalmol. 2008, 246:573-580.
32. Joachim S.C., Grus F.H., Kraft D., White-Farrar K., Barnes G., Barbeck M., Ghanaati S., Cao S., Li B., Wax M.B. Complex antibody profile changes in an experimental autoimmune glaucoma animal model. Invest. Ophthalmol. Vis. Sci. 2009, 50:4734-4742.
33. Johnson E.C., Deppmeier L.M., Wentzien S.K., Hsu I., Morrison J.C. Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 2000, 41:431-442.
34. Johnson E.C., Jia L., Cepurna W.O., Doser T.A., Morrison J.C. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 2007, 48:3161-3177.
35. Johnson E.C., Doser T.A., Dyck J.A., Guo Y., Lambert W.S., Cepurna W.O., Morrison J.C. Early optic nerve head astrocytic reaction to elevated intraocular pressure is characterized by dedifferentiation and proliferation. Invest. Ophthalmol. Vis. Sci. 2010, 51. E-Abstract 5215. Available at:. http://www.iovs.org.
36. Johnson E.C., Morrison J.C. Friend or foe? Resolving the impact of glial responses in glaucoma. J. Glaucoma 2009, 18:341-353.
37. Jonas J.B., Schmidt A.M., Muller-Bergh J.A., Schlotzer-Schrehardt U.M., Naumann G.O. Human optic nerve fiber count and optic disc size. Invest. Ophthalmol. Vis. Sci. 1992, 33:2012-2018.
38. Ju K.R., Kim H.S., Kim J.H., Lee N.Y., Park C.K. Retinal glial cell responses and Fas/FasL activation in rats with chronic ocular hypertension. Brain Res. 2006, 1122:209-221.
39. Kaszubowska L. Telomere shortening and ageing of the immune system. J. Physiol. Pharmacol. 2008, 59(Suppl. 9):169-186.
40. Ko M.L., Peng P.H., Ma M.C., Ritch R., Chen C.F. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic. Biol. Med. 2005, 39:365-373.
41. Kompass K.S., Agapova O.A., Li W., Kaufman P.L., Rasmussen C.A., Hernandez M.R. Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci. 2008, 9:93.
42. Kong G.Y., Van Bergen N.J., Trounce I.A., Crowston J.G. Mitochondrial dysfunction and glaucoma. J. Glaucoma 2009, 18:93-100.
43. Kuehn M.H., Kim C.Y., Ostojic J., Bellin M., Alward W.L., Stone E.M., Sakaguchi D.S., Grozdanic S.D., Kwon Y.H. Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp. Eye Res. 2006, 83:620-628.
44. Lam T.T., Kwong J.M., Tso M.O. Early glial responses after acute elevated intraocular pressure in rats. Invest. Ophthalmol. Vis. Sci. 2003, 44:638-645.
45. Leibovitch I., Kurtz S., Kesler A., Feithliher N., Shemesh G., Sela B.A. C-reactive protein levels in normal tension glaucoma. J. Glaucoma 2005, 14:384-386.
46. Levin L.A. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy. Surv. Ophthalmol. 1999, 43(Suppl. 1):S98-S101.
47. Lin L. RAGE on the toll road?. Cell. Mol. Immunol. 2006, 3:351-358.
48. Liu B., Neufeld A.H. Expression of nitric oxide synthase-2 in reactive astrocytes of the human glaucomatous optic nerve head. Glia 2000, 30:178-186.
49. Luo C., Thornton I., Yang X., Soltau J.B., Tezel G. Serum biomarkers in glaucoma patients: oxidized proteins. Invest. Ophthalmol. Vis. Sci. 2010, 51. E-Abstract 2670. Available at:. http://www.iovs.org.
50. Luo, C., Yang, X., Kain, A., Powell, D., Kuehn, M.H., Tezel, G., 2010b. Glaucomatous tissue stress and the regulation of immune response through the glial toll-like receptor signaling. Invest. Ophthalmol. Vis. Sci. 51 (2010), doi:10.1167/iovs.10-540.
51. Malone P.E., Hernandez M.R. 4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes. Exp. Eye Res. 2007, 84:444-454.
52. Martin K.R., Levkovitch-Verbin H., Valenta D., Baumrind L., Pease M.E., Quigley H.A. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest. Ophthalmol. Vis. Sci. 2002, 43:2236-2243.
53. Maruyama I., Ohguro H., Ikeda Y. Retinal ganglion cells recognized by serum autoantibody against gamma-enolase found in glaucoma patients. Invest. Ophthalmol. Vis. Sci. 2000, 41:1657-1665.
54. Matsubara T., Pararajasegaram G., Wu G.S., Rao N.A. Retinal microglia differentially express phenotypic markers of antigen-presenting cells in vitro. Invest. Ophthalmol. Vis. Sci. 1999, 40:3186-3193.
55. Maue A.C., Yager E.J., Swain S.L., Woodland D.L., Blackman M.A., Haynes L. T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 2009, 30:301-305.
56. McKinnon S.J., Kasmala L.T., Dixon A.L. Severe B- and T-lymphocyte immunodeficiency caused by Rag1 knockout prevents optic nerve axon loss in a mouse glaucoma model. Invest. Ophthalmol. Vis. Sci. 2010, 51. E-Abstract 2523. Available at:. http://www.iovs.org.
57. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
58. Miao H., Chen L., Riordan S.M., Li W., Juarez S., Crabb A.M., Lukas T.J., Du P., Lin S.M., Wise A., Agapova O.A., Yang P., Gu C.C., Hernandez M.R. Gene expression and functional studies of the optic nerve head astrocyte transcriptome from normal African Americans and Caucasian Americans donors. PLoS One 2008, 3:e2847.
59. Mikelberg F.S., Drance S.M., Schulzer M., Yidegiligne H.M., Weis M.M. The normal human optic nerve. Axon count and axon diameter distribution. Ophthalmology 1989, 96:1325-1328.
60. Miyahara T., Kikuchi T., Akimoto M., Kurokawa T., Shibuki H., Yoshimura N. Gene microarray analysis of experimental glaucomatous retina from cynomologous monkey. Invest. Ophthalmol. Vis. Sci. 2003, 44:4347-4356.
61. Moreno M.C., Sande P., Marcos H.A., de Zavalia N., Keller Sarmiento M.I., Rosenstein R.E. Effect of glaucoma on the retinal glutamate/glutamine cycle activity. FASEB J. 2005, 19:1161-1162.
62. Morgan J.E. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage. Eye 2000, 14(Pt 3B):437-444.
63. Nakazawa T., Nakazawa C., Matsubara A., Noda K., Hisatomi T., She H., Michaud N., Hafezi-Moghadam A., Miller J.W., Benowitz L.I. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J. Neurosci. 2006, 26:12633-12641.
64. Naskar R., Wissing M., Thanos S. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2002, 43:2962-2968.
65. Neufeld A.H. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma. Surv. Ophthalmol. 1999, 43(Suppl. 1):S129-S135.
66. Neufeld A.H. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch. Ophthalmol. 1999, 117:1050-1056.
67. Neufeld A.H., Hernandez M.R., Gonzalez M., Geller A. Cyclooxygenase-1 and cyclooxygenase-2 in the human optic nerve head. Exp. Eye Res. 1997, 65:739-745.
68. Neufeld A.H., Liu B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist 2003, 9:485-495.
69. Neumann H. Control of glial immune function by neurons. Glia 2001, 36:191-199.
70. Nickells R.W. From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can. J. Ophthalmol. 2007, 42:278-287.
71. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
72. Nishioku T., Matsumoto J., Dohgu S., Sumi N., Miyao K., Takata F., Shuto H., Yamauchi A., Kataoka Y. Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. J. Pharmacol. Sci. 2010, 112:251-254.
73. van Noort J.M., van Sechel A.C., Bajramovic J.J., el Ouagmiri M., Polman C.H., Lassmann H., Ravid R. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995, 375:798-801.
74. Odoardi F., Kawakami N., Klinkert W.E., Wekerle H., Flugel A. Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:18625-18630.
75. Osborne N.N. Pathogenesis of ganglion " cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Prog. Brain Res. 2008, 173:339-352.
76. Osborne N.N. Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma. Exp. Eye Res. 2010, 90:750-757.
77. Panagis L., Zhao X., Ge Y., Ren L., Mittag T.W., Danias J. Gene expression changes in areas of focal loss of retinal ganglion cells in the retina of DBA/2J mice. Invest. Ophthalmol. Vis. Sci. 2010, 51:2024-2034.
78. Panda A., Arjona A., Sapey E., Bai F., Fikrig E., Montgomery R.R., Lord J.M., Shaw A.C. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol. 2009, 30:325-333.
79. Pender M.P., Rist M.J. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 2001, 36:137-144.
80. Pun P.B., Lu J., Moochhala S. Involvement of ROS in BBB dysfunction. Free Radic. Res. 2009, 43:348-364.
81. Quigley H.A. Glaucoma: macrocosm to microcosm the Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 2005, 46:2662-2670.
82. Ransohoff R.M., Perry V.H. Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 2009, 27:119-145.
83. Ransom B., Behar T., Nedergaard M. New roles for astrocytes (stars at last). Trends Neurosci. 2003, 26:520-522.
84. Reichelt J., Joachim S.C., Pfeiffer N., Grus F.H. Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. Curr. Eye Res. 2008, 33:253-261.
85. Repka M.X., Quigley H.A. The effect of age on normal human optic nerve fiber number and diameter. Ophthalmology 1989, 96:26-32.
86. Schwartz M. Macrophages and microglia in central nervous system injury: are they helpful or harmful?. J. Cereb. Blood Flow Metab. 2003, 23:385-394.
87. Schwartz M. Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture. Invest. Ophthalmol. Vis. Sci. 2003, 44:1407-1411.
88. Schwartz M., Kipnis J. Autoimmunity on alert: naturally occurring regulatory CD4(+)CD25(+) T cells as part of the evolutionary compromise between a 'need' and a 'risk'. Trends Immunol. 2002, 23:530-534.
89. Schwartz M., Ziv Y. Immunity to self and self-maintenance: a unified theory of brain pathologies. Trends Immunol. 2008, 29:211-219.
90. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
91. Son J.L., Soto I., Oglesby E., Lopez-Roca T., Pease M.E., Quigley H.A., Marsh-Armstrong N. Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia 2010, 58:780-789.
92. Stasi K., Nagel D., Yang X., Wang R.F., Ren L., Podos S.M., Mittag T., Danias J. Complement component 1Q upregulation in retina of murine, primate, and human glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2006, 47:1024-1029.
93. Steele M.R., Inman D.M., Calkins D.J., Horner P.J., Vetter M.L. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2006, 47:977-985.
94. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
95. Stoll G., Jander S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol. 1999, 58:233-247.
96. Streit W.J. The role of microglia in brain injury. Neurotoxicology 1996, 17:671-678.
97. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006, 29:506-510.
98. Su W.W., Ho W.J., Cheng S.T., Chang S.H., Wu S.C. Systemic high-sensitivity C-reactive protein levels in normal-tension glaucoma and primary open-angle glaucoma. J. Glaucoma 2007, 16:320-323.
99. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 2006, 25:490-513.
100. Tezel G. TNF-alpha signaling in glaucomatous neurodegeneration. Prog. Brain Res. 2008, 173:409-421.
101. Tezel G. The role of glia, mitochondria, and the immune system in glaucoma. Invest. Ophthalmol. Vis. Sci. 2009, 50:1001-1012.
102. Tezel G., Seigel G.M., Wax M.B. Autoantibodies to small heat shock proteins in glaucoma. Invest. Ophthalmol. Vis. Sci. 1998, 39:2277-2287.
103. Tezel G., Hernandez M.R., Wax M.B. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch. Ophthalmol. 2000, 118:511-518.
104. Tezel G., Li L.Y., Patil R.V., Wax M.B. Tumor necrosis factor-alpha and its receptor-1 in the retina of normal and glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2001, 42:1787-1794.
105. Tezel G., Chauhan B.C., LeBlanc R.P., Wax M.B. Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma. Invest. Ophthalmol. Vis. Sci. 2003, 44:3025-3033.
106. Tezel G., Yang X., Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2005, 46:3177-3187.
107. Tezel G., Luo C., Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest. Ophthalmol. Vis. Sci. 2007, 48:1201-1211.
108. Tezel G., Yang X., Luo C., Peng Y., Sun S.L., Sun D. Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest. Ophthalmol. Vis. Sci. 2007, 48:705-714.
109. Tezel G., Yang X., Luo C., Peng Y., Sun D., Kaplan H.J. T cell-mediated autoimmune component of glaucomatous neurodegeneration in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2008, 49. E-Abstract 3699. Available at:. http://www.iovs.org.
110. Tezel, G., Yang, X., Luo, C., Kain, A., Powell, D., Kuehn, M.H., Kaplan, H.J. Oxidative stress and the regulation of complement activation in human glaucoma. Invest. Ophthalmol. Vis. Sci. 51 (2010), doi:10.1167/iovs.10-5289.
111. Tezel G., Wax M.B. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J. Neurosci. 2000, 20:3552-3562.
112. Tezel G., Wax M.B. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci. 2000, 20:8693-8700.
113. Tezel G., Wax M.B. The immune system and glaucoma. Curr. Opin. Ophthalmol. 2004, 15:80-84.
114. Tezel G., Wax M.B. Glaucoma. Chem. Immunol. Allergy 2007, 92:221-227.
115. Tezel G., Yang X. Caspase-independent component of retinal ganglion cell death, in vitro. Invest. Ophthalmol. Vis. Sci. 2004, 45:4049-4059.
116. Tezel G., Yang X. Comparative gene array analysis of TNF-alpha-induced MAPK and NF-kappaB signaling pathways between retinal ganglion cells and glial cells. Exp. Eye Res. 2005, 81:207-217.
117. Thornton I., Luo C., Yang X., Soltau J.B., Tezel G. Immunoproteomic analysis of glaucomatous patient serum and aqueous humor antibodies: differential immunoreactivity against glaucomatous versus non-glaucomatous retinal proteins. Invest. Ophthalmol. Vis. Sci. 2010, 51. E-Abstract 2673. Available at:. http://www.iovs.org.
118. Vargas M.E., Barres B.A. Why is Wallerian degeneration in the CNS so slow?. Annu. Rev. Neurosci. 2007, 30:153-179.
119. Wang X., Tay S.S., Ng Y.K. An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp. Brain Res. 2000, 132:476-484.
120. Wang L., Cioffi G.A., Cull G., Dong J., Fortune B. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest. Ophthalmol. Vis. Sci. 2002, 43:1088-1094.
121. Wang A.L., Yuan M., Neufeld A.H. Age-related changes in neuronal susceptibility to damage: comparison of the retinal ganglion cells of young and old mice before and after optic nerve crush. Ann. N. Y. Acad. Sci. 2007, 1097:64-66.
122. Wax M.B., Barrett D.A., Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am. J. Ophthalmol. 1994, 117:561-568.
123. Wax M.B., Tezel G., Edward P.D. Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma. Arch. Ophthalmol. 1998, 116:993-1001.
124. Wax M.B., Tezel G., Saito I., Gupta R.S., Harley J.B., Li Z., Romano C. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am. J. Ophthalmol. 1998, 125:145-157.
125. Wax M.B., Tezel G., Yang J., Peng G., Patil R.V., Agarwal N., Sappington R.M., Calkins D.J. Induced autoimmunity to heat shock proteins elicits glaucomatous loss of retinal ganglion cell neurons via activated T-cell-derived fas-ligand. J. Neurosci. 2008, 28:12085-12096.
126. Wax M.B., Tezel G. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp. Eye Res. 2009, 88:825-830.
127. Weinreb R.N., Khaw P.T. Primary open-angle glaucoma. Lancet 2004, 363:1711-1720.
128. Wekerle H., Sun D., Oropeza-Wekerle R.L., Meyermann R. Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells. J. Exp. Biol. 1987, 132:43-57.
129. Woldemussie E., Wijono M., Ruiz G. Muller cell response to laser-induced increase in intraocular pressure in rats. Glia 2004, 47:109-119.
130. Xu H., Chen M., Forrester J.V. Para-inflammation in the aging retina. Prog. Retin. Eye Res. 2009, 28:348-368.
131. Yan X., Tezel G., Wax M.B., Edward D.P. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch. Ophthalmol. 2000, 118:666-673.
132. Yang J., Patil R.V., Yu H., Gordon M., Wax M.B. T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am. J. Ophthalmol. 2001, 131:421-426.
133. Yang J., Yang P., Tezel G., Patil R.V., Hernandez M.R., Wax M.B. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. Invest. Ophthalmol. Vis. Sci. 2001, 42:365-371.
134. Yang X., Luo C., Cai J., Pierce W.M., Tezel G. Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 2008, 49:2483-2494.
135. Young D.B. Heat-shock proteins: immunity and autoimmunity. Curr. Opin. Immunol. 1992, 4:396-400.
136. Yuan L., Neufeld A.H. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 2000, 32:42-50.
137. Yung R.L., Julius A. Epigenetics, aging, and autoimmunity. Autoimmunity 2008, 41:329-335.
138. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.